Details for New Drug Application (NDA): 070852
✉ Email this page to a colleague
NDA 070852 describes PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, which is a drug marketed by Actavis Elizabeth, Ani Pharms, Chartwell Rx, Ivax Sub Teva Pharms, Rising, Warner Chilcott, and Watson Labs, and is included in fifteen NDAs. Additional details are available on the PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE profile page.
The generic ingredient in PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; propranolol hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.
The generic ingredient in PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; propranolol hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.
Summary for 070852
| Tradename: | PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE |
| Applicant: | Actavis Elizabeth |
| Ingredient: | hydrochlorothiazide; propranolol hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG;80MG | ||||
| Approval Date: | May 15, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
